Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Non Operating Income (2018 - 2025)

Historic Non Operating Income for Neurogene (NGNE) over the last 5 years, with Q3 2025 value amounting to $2.8 million.

  • Neurogene's Non Operating Income rose 4493.12% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.2 million, marking a year-over-year increase of 10672.1%. This contributed to the annual value of $7.5 million for FY2024, which is 6127.37% down from last year.
  • As of Q3 2025, Neurogene's Non Operating Income stood at $2.8 million, which was up 4493.12% from $4.1 million recorded in Q2 2025.
  • Neurogene's 5-year Non Operating Income high stood at $4.1 million for Q2 2025, and its period low was $1.6 million during Q2 2024.